<?xml version="1.0" encoding="UTF-8"?>
<p>It is thought that organ transplanted patients have reduced the severity of lung injury and atypical symptoms of COVID-19. Although transplanted patients could be more susceptible to COVID-19 infection with atypical manifestations, the chronic use of immunosuppressive drugs could potentially represent a “protective factor” for the severe clinical complication of the disease through excessive cytokine reaction. However, there has been conflicting data from different parts of the world on this subject.</p>
